4/A//SEC Filing
ANDERSON ELIZABETH M 4/A
Accession 0001610717-24-000379
CIK 0001628171other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 5:09 PM ET
Size
7.9 KB
Accession
0001610717-24-000379
Insider Transaction Report
Form 4/AAmended
ANDERSON ELIZABETH M
Director
Transactions
- Award
Common Stock
2024-06-20+4,248→ 20,073 total - Award
Stock Option (Right to Buy)
2024-06-20+15,955→ 15,955 totalExercise: $37.54Exp: 2034-06-19→ Common Stock (15,955 underlying)
Holdings
- 26,990(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]Held by David W. Anderson 1996 Irrevocable Trust.
- [F2]Includes 4,248 restricted stock units ("RSUs").
- [F3]Shares subject to the Stock Option shall vest in full on the earlier of (i) the first anniversary of June 20, 2024 or (ii) immediately prior to the Issuer's annual meeting of stockholders following the date of grant, subject to the Reporting Person continuing in service through the vesting date.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001758247
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 5:09 PM ET
- Size
- 7.9 KB